Over the last 15-20 years, the UK has come to be seen by some in the global pharmaceutical industry as a problematic, low growth market which has erected many barriers to market access for new ...

A UK market access summit convened by IQVIA brought together pharma and NHS leaders to look at how working more closely – including more outcomes-based deals – could help UK life sciences ...

The European Pharma Handbook provides pharmaceutical industry decision-makers with a single source of accurate, up-to-date statistics, information and analysis on prescription drug business and ...

Dublin, April 18, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Cold Chain Packaging Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ...

“That was a big wow,” says Trung Huynh, head of pharma analysis at UBS ... really problematic for the UK economy.” Trump’s problem with the pharmaceutical industry goes beyond America ...

GSK said on Thursday two combination therapies with its cancer drug, Blenrep, have received approval from British authorities ...

And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with ... However, the pharmaceutical industry’s complicated supply chains and ...

ONT, which was IP Group’s largest holding at end-2024 (13% of portfolio value), offers a new generation of nanopore-based sensing technology, enabling the real-time, high-performance, accessible and ...

Trump's exemption of pharma from the ... Please conduct your own analysis or seek professional advice before investing. Remember, investments are subject to market risks and past performance ...

It is affecting the US market, too. The markets ... 25 per cent – will still apply to the UK. There are also concerns that pharmaceuticals, another major UK export to the US, currently excluded ...

The MHRA believes this is the first analysis conducted by a UK regulator to ... that despite Lord James O'Shaughnessy's previous evaluation of the UK clinical trial landscape, pharmaceutical and ...

The first comprehensive analysis of clinical trials in the UK has found the country remains ... Unfettered access to industry-leading news, commentary and analysis in pharma and biotech. Updates from ...